Navigation Links
Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
Date:9/17/2008

ls in clinical medicine. Until a radiographic test can meet that standard, gastroenterologists will continue to champion the lifesaving potential of colonoscopy," Foxx-Orenstein added.

Evaluating the Potential of CT Colonography - What Patients Should Know

When evaluating new potential screening technologies, including CT colonography, the ACG has focused its evaluation on several pieces of evidence including: sensitivity for identification of polyps of various sizes, standards for polyp removal, correlating patient risks (in this case from radiation exposure), frequency of exams and the economic impact to the healthcare system of separate diagnostic and therapeutic exams.

If all patients with a lesion measuring 5 mm or more on CT colonography in this study were referred for complete colonoscopy, the colonoscopy-referral rate would be 17 percent. In earlier findings by Dr. Pickhardt and his colleagues in 2004, at least 30 percent of patients undergoing virtual colonoscopy required conventional colonoscopy to remove polyps 6 mm or larger.

Radiation Risk

The issue of radiation exposure risk are long-term and lifetime risks. The results of the impact of patients undergoing CT and other radiologic exams for a variety of reasons will not be known for some time. With a proposed screening schedule of five years or less for CTC, depending upon the findings, the cancer risks from the CTC test itself are not insignificant. Although it is a challenge to define precise risk estimates related to low doses of radiation exposure, the ionizing radiation exposure from a single abdominal or chest CT may be associated with elevated risk for DNA damage and cancer formation. X-rays used in medical diagnostic procedures is the largest man-made source of radiation exposure to the population contributing some 14 percent of the total annual exposure from all sources. The U.S. Food and Drug Administration considers x-ray as a carcinogen.

Patient Acce
'/>"/>

SOURCE American College of Gastroenterology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
2. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
5. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
6. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
7. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
8. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
9. Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
10. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
11. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire-FirstCall/--EchoTherapeutics,Inc.(OTCBulleti...ony(TM)tCGMSystemasanon-invasive,wireless,transder...elude(TM)SkinPrepSystemfortransdermaldrugdelivery,...ChiefExecutiveOfficer,willpresentatthe13thAnnualBi...edbytheNewYorkSocietyofSecuritiesAnalysts,at2:05on...
(Date:11/24/2009)...e/--MAQUETCardiovascularLLC,aleadingproviderofcard...edaguaranteedtwo-yearcontractwithNovation,oneofthe...esolesourceproviderofsurgicaldevicesforbeatinghear...,whichrunsthroughOctober31,2012,MAQUETCardiovascul...nddisposablesuppliestothemembersofVHAInc.andUniver...
(Date:11/24/2009)...wswire-FirstCall/--IsisPharmaceuticals,Inc.(Nasdaq...ouncedthatmanagementwillpresentacompanyoverviewatP...ay,December1,2009,at10:30a.m.ETatTheNewYorkPalaceH...beavailableonthe"Investors&Media"sectionoftheC...esentationwillbeavailableontheIsisWebsitewithin48h...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Safe Ozone Levels May Not Be for Some 52829 1Safe Ozone Levels May Not Be for Some 52829 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 1Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 2
...DIEGO, Dec. 5 Orexigen(R) Therapeutics, Inc.,(Nas...the Company,s resources,focus its efforts on its l...ent team. , The key aspects of these changes...-of-concept Phase 2 trials for OREX-003,(zonisamid...ted weight gain),and OREX-004 (fluoxetine and nalt...
...ERDAM, December 4 Biopharmaceutical company Kiadi...completed treatment of the,last patient on its ATI...,lymphocyte cell based product, is under developme...D) and allow early immune reconstitution following...n end stage blood cancer,patients were treated wit...
Other Medicine Technology:Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 2Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 3Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2
(Date:11/24/2009)....24/PRNewswire/--Whiletheholidayseasonoftenbringsf...yearcanbedifficultforthosegrievingthedeathofaloved...andfamilies.Theholidayseasoncanbringadditionalchal...ngPlace,ACenterforGrievingChildren,AdolescentsandT...dditiontohavingavarietyofprintandonlineresourcesav...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--HealthSouthCorpora...heBankofAmericaMerrillLynch2009CreditConferenceinN...residentandTreasurerEdFaywillbespeakingonThursday,...stliveandwillbeavailableat http://investor.healths...HealthSouth ,, HealthSouthisthenation,slargest...
(Date:11/24/2009)...s didn,t differ greatly between high- and low-volu.... 24 (HealthDay News) -- Do hospitals that conduct...st results for patients? Maybe not. , Prior res...when it comes to artery-opening procedures, but a ...- and high-volume hospitals performing more or les...
(Date:11/24/2009)...a,Nov.24/PRNewswire-FirstCall/-HardtoTreatDiseases...gsubsidiarySlavicaBioChem,isprovidingthisbriefupda...inuesduediligencewiththeEUstemcellcompanyandmerger...oraboutOct29,2009whichthecompanymade. http://www.p...News . ,, HTDSandSlavicaBiochemarealsodiscussin...
(Date:11/24/2009)...24/PRNewswire/--Metastorm,aleadingproviderofBusine...PA),andEnterpriseArchitecture(EA)softwareforaligni...merisourceBergenCorporation,oneoftheworld,slargest...rdforNorthAmericainthe2009GlobalAwardsforExcellenc...implementationofMetastorm,sBPMsoftware.Theawardrec...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2
...arch 5 AmericInn(R) International, LLC officially...,s new sleep advocacy and awareness campaign, with.... The new Web portal is designed to educate consum...ter America" Web site centralizes unique sleep-rel...
... 3, 2009) - How messages sent within stem cells th... the cells to specialize and become blood cells in...McMaster Stem Cell and Cancer Research Institute. ...way, known as the noncanonical Wnt, in inducing bl...
...lternative Reproductive Resources (ARR) today ann...economic realities given the investment required f... Alternatives ," it offers incentive pricing to in...ome egg donors," said Robin von Halle, president o...
...cabbage block protein in disease spread, study say...- A drug based on compounds extracted from crucife... offer a potent and safe treatment against melanom...production and blocked the signaling network of a ...
... and Asia to Realize New Executive Leadership , ,...okyo Stock Exchange), a leading medical diagnosti...ion systems developer, today announced executive l... Sysmex Corporate after a six-year tenure in the U...
...clinical trial involving more than 3,000 women in ...first time the promise of a vaginal microbicide ge... to findings presented at the Conference on Retrov...30% effective. While the results are encouraging, ...
Other Medicine News:Health News:AmericInn Hotels Kicks-Off 'Sleep Better America' With Launch of New Web Site to Educate Consumers About Insomnia and Sleep-Related Issues 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Clinical trial finds microbicide promising as HIV prevention method for women 2
Kerrison style punch
Aaron 2250 Electrosurgery Generator
Sabre 2400 Electrosurgery Generator, 240V, 50Hz
ExcaliburPlus PC Electrosurgery Generator, 100V, 50Hz/60Hz
Medicine Products: